The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol

Pfizer Antiviral Hiv Drug

Here's a taste of what has to offer on this topic:
U.S. Centers for Disease Control and Prevention

FDA Panel to Consider Pfizer's Second-Line HIV Drug

On April 24, the Food and Drug Administration's antiviral drugs advisory panel will review maraviroc, a new CCR5 antagonist candidate made by Pfizer. The agency said Thursday its panel will evaluate the twice-daily pill's safety and efficacy data. ... Read more »
Henry J. Kaiser Family Foundation

GlaxoSmithKline, Pfizer Formally Launch Company to Develop New HIV Treatments

Pharmaceutical companies GlaxoSmithKline (GSK) and Pfizer on Tuesday formally launched ViiV Healthcare , a company focused on the development of new HIV treatments, Dow Jones Newswires/ reports (11/3). "GSK was at the forefront of... Read more »
Henry J. Kaiser Family Foundation

GSK, Pfizer Announce Combined HIV/AIDS Drug Business

Pharmaceutical companies GlaxoSmithKline and Pfizer have announced that they will combine their HIV/AIDS drug businesses into a new, single company, the Wall Street Journal reports. Under the deal, GSK initially will hold 85% of the joint... Read more »
Ask the Experts


Hello Dr. Bob,Does antiviral drugs as of "FOSCARNET SODIUM INJECTION" AND "RECOMBINANT HURNAN INTERLEUKIN-2" interfere with the HIV antibody test? Would this postpone the development of antibody?I was on the above mentioned...
Robert J. Frascino, M.D.

Response from Robert J. Frascino, M.D.

The Robert James Frascino AIDS Foundation
Hello,Your doctor prescribed Foscarnet and Interleukin-2 for "suspicion of possible HSV-2 and HPV?" Really? OK, first thing to do is find a different doctor, as this is not recommended treatment.Second, will these therapies affect your HIV... Read more »

HIV antivirals and Medicare Drug Plan

I am HIV positive and currently receiving SSDI benefits, and have been working through Social Security's "Return to Work" program for the past few years. However, my current position ends in May 2010 and so does the insurance...
Nancy Breuer

Response from Nancy Breuer

WorkPositive, Inc.
While you are in this window, you might qualify for your prescription drug manufacturer's patient assistance program. If you go to the website for your medication, you should be directed to information on applying for patient assistance. If you... Read more »

Thank you for guidance on antiviral-naive patient

Dear Dr.Wohl, Thank you very much for your guidance on my question (below I copied). I start my treatment tomorrow. With your response, I also think that it is a win-win: I) I am under the supervision of Goethe Hospital, HIV Clinic in Frankfurt...
David Wohl, M.D.

Response from David Wohl, M.D.

University of North Carolina - Chapel Hill
Wonderful. Good luck, Jay. DW... Read more »

Antiviral-naive patient about to start medication in a study

Dear The Body Doctors,I am 38 years old male from Belgium, I am HIV+ since May 2006, my first CD4 count was 700, and viral load was 3000 at that time. As of December 2011, my CD4 load is down to 490, and viral load is up to 34.000. I work for an...
David Wohl, M.D.

Response from David Wohl, M.D.

University of North Carolina - Chapel Hill
Given the drop in your CD4 cell count I would say that you should start HIV medications and no wait, no matter how you get your meds. A clinical trial is a great way to get free drugs (and labs and attention) plus help others. The thing is that... Read more »
Connect With Others

the best source of anti-viral meds

Posted by lola70
all kinds of life-style drugs are available on! 24/7 support and the best prices! Read more »

Anyone else taking Drug Holidays?

Posted by Anonymous, 2 Replies
Hi everyone, new to this Bulliten Board, but was wondering if anyone else has taken a drug holiday, I know most doctors DO NOT agree with doing this, but was just wondering.

Read more »


Posted by Anonymous
Recruitment to Open for Peptide T Anti-Viral Trial

(Contact Diane Cenko, HIVCARE Client Outreach Coordinator, 415-353-6215 or 6259)

San Francisco, Calif. - February, 2001 -- A phase II study of Peptide T to evaluate its... Read more »